全文获取类型
收费全文 | 2461篇 |
免费 | 334篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 4篇 |
儿科学 | 18篇 |
妇产科学 | 47篇 |
基础医学 | 60篇 |
临床医学 | 1987篇 |
内科学 | 110篇 |
皮肤病学 | 6篇 |
神经病学 | 63篇 |
特种医学 | 33篇 |
外科学 | 95篇 |
综合类 | 2篇 |
预防医学 | 240篇 |
眼科学 | 6篇 |
药学 | 25篇 |
肿瘤学 | 102篇 |
出版年
2024年 | 1篇 |
2023年 | 30篇 |
2022年 | 4篇 |
2021年 | 28篇 |
2020年 | 34篇 |
2019年 | 33篇 |
2018年 | 87篇 |
2017年 | 93篇 |
2016年 | 84篇 |
2015年 | 115篇 |
2014年 | 116篇 |
2013年 | 130篇 |
2012年 | 77篇 |
2011年 | 63篇 |
2010年 | 65篇 |
2009年 | 89篇 |
2008年 | 52篇 |
2007年 | 56篇 |
2006年 | 60篇 |
2005年 | 33篇 |
2004年 | 34篇 |
2003年 | 29篇 |
2002年 | 30篇 |
2001年 | 59篇 |
2000年 | 25篇 |
1999年 | 106篇 |
1998年 | 149篇 |
1997年 | 154篇 |
1996年 | 211篇 |
1995年 | 168篇 |
1994年 | 161篇 |
1993年 | 106篇 |
1992年 | 83篇 |
1991年 | 73篇 |
1990年 | 57篇 |
1989年 | 42篇 |
1988年 | 24篇 |
1987年 | 15篇 |
1986年 | 5篇 |
1985年 | 7篇 |
1984年 | 2篇 |
1982年 | 5篇 |
1981年 | 3篇 |
排序方式: 共有2798条查询结果,搜索用时 15 毫秒
101.
102.
A ten‐year review of soft tissue reactions around percutaneous titanium implants for auricular prosthesis 下载免费PDF全文
103.
104.
105.
Kröger C Dillon SC Cameron AD Papenfort K Sivasankaran SK Hokamp K Chao Y Sittka A Hébrard M Händler K Colgan A Leekitcharoenphon P Langridge GC Lohan AJ Loftus B Lucchini S Ussery DW Dorman CJ Thomson NR Vogel J Hinton JC 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(20):E1277-E1286
106.
Fleur E. Brölmann MD Anne M. Eskes MSc PhD Bauer E. Sumpio MD PhD Dieter O. Mayer MD Zena Moore RGN PhD Magnus S. Ågren DMSci Michel Hermans MD Keith Cutting MSc RN Dink A. Legemate MD PhD Hester Vermeulen RN PhD Dirk T. Ubbink MD PhD 《Wound repair and regeneration》2013,21(5):641-647
In wound care research, available high‐level evidence according to the evidence pyramid is rare, and is threatened by a poor study design and reporting. Without comprehensive and transparent reporting, readers will not be able to assess the strengths and limitations of the research performed. Randomized clinical trials (RCTs) are universally acknowledged as the study design of choice for comparing treatment effects. To give high‐level evidence the appreciation it deserves in wound care, we propose a step‐by‐step reporting standard for comprehensive and transparent reporting of RCTs in wound care. Critical reporting issues (e.g., wound care terminology, blinding, predefined outcome measures, and a priori sample size calculation) and wound‐specific barriers (e.g., large diversity of etiologies and comorbidities of patients with wounds) that may prevent uniform implementation of reporting standards in wound care research are addressed in this article. The proposed reporting standards can be used as guidance for authors who write their RCT, as well as for peer reviewers of journals. Endorsement and application of these reporting standards may help achieve a higher standard of evidence and allow meta‐analysis of reported wound care data. The ultimate goal is to help wound care professionals make better decisions for their patients in clinical practice. 相似文献
107.
Aoife P. Kiely Yasmine T. Asi Eleanna Kara Patricia Limousin Helen Ling Patrick Lewis Christos Proukakis Niall Quinn Andrew J. Lees John Hardy Tamas Revesz Henry Houlden Janice L. Holton 《Acta neuropathologica》2013,125(5):753-769
We report a British family with young-onset Parkinson’s disease (PD) and a G51D SNCA mutation that segregates with the disease. Family history was consistent with autosomal dominant inheritance as both the father and sister of the proband developed levodopa-responsive parkinsonism with onset in their late thirties. Clinical features show similarity to those seen in families with SNCA triplication and to cases of A53T SNCA mutation. Post-mortem brain examination of the proband revealed atrophy affecting frontal and temporal lobes in addition to the caudate, putamen, globus pallidus and amygdala. There was severe loss of pigmentation in the substantia nigra and pallor of the locus coeruleus. Neuronal loss was most marked in frontal and temporal cortices, hippocampal CA2/3 subregions, substantia nigra, locus coeruleus and dorsal motor nucleus of the vagus. The cellular pathology included widespread and frequent neuronal α-synuclein immunoreactive inclusions of variable morphology and oligodendroglial inclusions similar to the glial cytoplasmic inclusions of multiple system atrophy (MSA). Both inclusion types were ubiquitin and p62 positive and were labelled with phosphorylation-dependent anti-α-synuclein antibodies In addition, TDP-43 immunoreactive inclusions were observed in limbic regions and in the striatum. Together the data show clinical and neuropathological similarities to both the A53T SNCA mutation and multiplication cases. The cellular neuropathological features of this case share some characteristics of both PD and MSA with additional unique striatal and neocortical pathology. Greater understanding of the disease mechanism underlying the G51D mutation could aid in understanding of α-synuclein biology and its impact on disease phenotype. 相似文献
108.
Expression of a polysaccharide capsule is required for the full pathogenicity of many mucosal pathogens such as Streptococcus pneumoniae. Although capsule allows for evasion of opsonization and subsequent phagocytosis during invasive infection, its role during mucosal colonization, the organism's commensal state, remains unknown. Using a mouse model, we demonstrate that unencapsulated mutants remain capable of nasal colonization but at a reduced density and duration compared to those of their encapsulated parent strains. This deficit in colonization was not due to increased susceptibility to opsonophagocytic clearance involving complement, antibody, or the influx of Ly-6G-positive cells, including neutrophils seen during carriage. Rather, unencapsulated mutants remain agglutinated within lumenal mucus and, thus, are less likely to transit to the epithelial surface where stable colonization occurs. Studies of in vitro binding to immobilized human airway mucus confirmed the inhibitory effect of encapsulation. Likewise, pneumococcal variants expressing larger amounts of negatively charged capsule per cell were less likely to adhere to surfaces coated with human mucus and more likely to evade initial clearance in vivo. Removal of negatively charged sialic acid residues by pretreatment of mucus with neuraminidase diminished the antiadhesive effect of encapsulation. This suggests that the inhibitory effect of encapsulation on mucus binding may be mediated by electrostatic repulsion and offers an explanation for the predominance of anionic polysaccharides among the diverse array of unique capsule types. In conclusion, our findings demonstrate that capsule confers an advantage to mucosal pathogens distinct from its role in inhibition of opsonophagocytosis--escape from entrapment in lumenal mucus. 相似文献
109.
It is generally accepted that cerebrospinal fluid (CSF) biomarkers such as tau protein, phosphorylated tau protein (threonine 181) and beta-amyloid (1-42) can facilitate early and differential diagnosis of Alzheimer's disease (AD). Since the respective concentrations can only be measured in a number of specialized centers, time to CSF specimen work-up has been considered as crucial for the stability of the respective biomarkers. When shipping of CSF samples is needed for biomarker measurement and immediate freezing of samples is not available, an overnight delay of up to 24h frequently occurs. Therefore, we investigated the potential impact of a 24h delayed freezing on CSF biomarker concentrations and compared it to 2h storage (room temperature, 20 degrees C) and an immediate freezing. First, storage at room temperature for 2h had only marginal, non-significant effects on the concentrations of CSF total tau protein and phospho-tau protein (181) compared to immediate freezing. Second, storage at room temperature for 24h did not significantly affect total tau protein or phospho-tau protein but beta-amyloid (1-42) concentrations which increased significantly compared to the samples frozen immediately. These results indicate that CSF samples for the evaluation of total tau and phospho-tau protein may be kept at room temperature for up to 24h whereas CSF samples for beta-amyloid (1-42) need to be frozen immediately. 相似文献
110.
Kieran A. Walsh Carol Sinnott Aoife Fleming Jenny Mc Sharry Stephen Byrne John Browne Suzanne Timmons 《Journal of the American Medical Directors Association》2018,19(11):948-958.e12